Therapy Areas: Oncology
19 February 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Thursday that the European Medicines Agency has validated a Type II variation application for Enhertu (tras...
19 February 2026 - Particle accelerator technology company Ion Beam Applications S.A. (IBA) (Euronext Brussels:IBAB) on Thursday announced a new agreement with Shreeji Imaging and Diagnostic Centre Pv...
19 February 2026 - US-based AVEO Oncology, an LG Chem (KRX:051910) company, announced on Wednesday that the 20mg/kg dose of ficlatuzumab has been chosen for the combination arm of the Phase 3 registra...
18 February 2026 - Pre-clinical stage immuno-oncology company Liminatus Pharma Inc (NASDAQ:LIMN) announced on Tuesday the pricing of its best-efforts public offering of 13,813,000 shares of its common...
17 February 2026 - First Ascent Biomedical, an oncology decision support platform, announced on Monday the official opening of a Functional Precision Medicine (FPM) laboratory in Miami, Florida.The Mi...
17 February 2026 - Immunology company Nucleome Therapeutics announced on Monday the appointment of Dr Michelle Morrow as its chief scientific officer (CSO), effective 23 February 2026.Dr Morrow has tw...